Aspirin's Protective Effects Against Liver Inflammation and Thrombus Formation in Mice
Author Information
Author(s): Saitoh Hayate, Sakaguchi Miina, Miruno Fumito, Muramatsu Naoto, Ito Nozomi, Tadokoro Kanako, Kawakami Kiyoharu, Nakadate Kazuhiko
Primary Institution: Meiji Pharmaceutical University
Hypothesis
Can aspirin mitigate liver inflammation and thrombus formation induced by lipopolysaccharide in mice?
Conclusion
Aspirin significantly reduces liver inflammation and thrombus formation in mice subjected to lipopolysaccharide treatment.
Supporting Evidence
- Aspirin pre-treatment significantly reduced inflammatory markers such as C-reactive protein, interleukin-1β, and tumor necrosis factor-alpha.
- Hepatocytes showed decreased eosin staining, indicating cellular shrinkage in LPS-treated mice.
- Electron microscopy confirmed thrombus formation within the liver due to LPS administration.
- Aspirin administration improved the area of hepatocytes and reduced the number of inflammatory cells in the liver.
- Thrombus formation was inhibited in the blood vessels of the liver with aspirin pre-treatment.
Takeaway
This study shows that giving aspirin to mice can help protect their livers from inflammation and blood clots caused by a harmful substance.
Methodology
The study involved administering lipopolysaccharide to mice and analyzing liver tissue for histopathological changes, with some mice pre-treated with aspirin.
Limitations
The study used an animal model that may not fully replicate human responses to lipopolysaccharide-induced inflammation.
Participant Demographics
42 eight-week-old male ICR mice
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website